Publications Office of the EU
EE-Tallinn: pharmaceutical products - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

EE-Tallinn: pharmaceutical products

  • Published
    11/11/2011
  • Deadline
    21/12/2011
  • Opening of tenders
    21/12/2011
  • Awarded
    03/02/2012
  • Today
    10/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
sihtasutus Põhja-Eesti Regionaalhaigla
Place of performance
NUTS code: EE Eesti
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
516,000.00 EUR
Total final contract value (excluding VAT)
402,081.00 EUR
Please consult each lot for details
Number of lots
2
Tender reference number
SAPER Apt 6-2011
Description

The purpose of this procurement is to procure low molecular heparins (B01AB) and other anti-thrombotic agents (B01AX) in accordance with the tables in Annex 1.

Submission Method
Not available
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
Conditions for opening tenders (date)
21/12/2011 10:00
Place of performance
CPV code
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.